Hennion & Walsh Asset Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,385
| Closed | -$2.26M | – | 843 |
|
|
2023
Q1 | $2.26M | Sell |
16,385
-561
| -3% | -$77.3K | 0.14% | 190 |
|
|
2022
Q4 | $2.2M | Buy |
16,946
+2,142
| +14% | +$278K | 0.14% | 193 |
|
|
2022
Q3 | $1.64M | Sell |
14,804
-205
| -1% | -$22.7K | 0.11% | 223 |
|
|
2022
Q2 | $1.13M | Sell |
15,009
-223
| -1% | -$16.7K | 0.07% | 287 |
|
|
2022
Q1 | $1.19M | Buy |
15,232
+311
| +2% | +$24.3K | 0.06% | 303 |
|
|
2021
Q4 | $1.34M | Buy |
14,921
+933
| +7% | +$84K | 0.07% | 299 |
|
|
2021
Q3 | $1.29M | Buy |
13,988
+4,790
| +52% | +$443K | 0.07% | 304 |
|
|
2021
Q2 | $715K | Buy |
+9,198
| New | +$715K | 0.04% | 439 |
|